Meyka Pro banner
Nevro Corp.

Nevro Corp. (NVRO) Stock Overview

Explore Nevro Corp.’s financial performance, market position, analyst ratings, and future outlook.

NVRONYSE
HealthcareMedical - Devices
$5.84
$0.00(0.00%)
U.S. Market opens in 3h 2m

Nevro Corp. (NVRO)

Meyka AI Score

Z

Key Financials

Market Cap224.1M
P/E Ratio-1.91
EPS (TTM)$-3.06
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

NVRO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Nevro Corp. (NYSE: NVRO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Nevro Corp.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NVRO on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NYSE listing.

Key metrics behind Nevro Corp.'s NYSE-traded stock include a P/E ratio of -1.91 and a market capitalization of 224.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NVRO on the NYSE.

Price Performance (NYSE: NVRO)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
15.19%
6-Month Change
5.61%
Year-to-Date (YTD) Change
57.41%
1-Year Change
-47.62%
3-Year Change
-90.72%
5-Year Change
-94.81%
All-Time (Max) Change
-76.82%

Contact Information

650 251 0005
1800 Bridge Parkway, Redwood City, CA, 94065

Company Facts

10,990 Employees
IPO DateNov 6, 2014
CountryUS

Frequently Asked Questions